Skip to main content

Perspectives in Pharmacological Therapy Targeting Cellular Metabolic Pathways in Respiratory Diseases

Cover image for Research Topic "Perspectives in Pharmacological Therapy Targeting Cellular Metabolic Pathways in Respiratory Diseases"
86kviews
Editorial27 November 2023
Editorial: Perspectives in pharmacological therapy targeting cellular metabolic pathways in respiratory diseases

showed that both Illumina and BGI mNGS platforms outperformed conventional methods in sensitivity, with negligible differences between each platform. This implies that mNGS can enhance pulmonary infection diagnosis by providing earlier pathogen identification, honing treatment precision, and enriching epidemiological insights. The rising incidence and mortality of fungal infections, including pulmonary mycosis, underscore the urgency for the demand of precise diagnosis and efficient treatment (9). Bronchoscopic instillation has been hailed as a novel therapeutic approach for pulmonary mycosis, offering precise local targeting of lesions.However, there has been a lack corroborated clinical data, specific indicators, or parameters gauging the efficacy of this strategy for patients (10). Yang and colleagues conducted a study, involving 80 patients, examined bronchoscopic instillation of amphotericin B. The results showed 72.5% of patients experienced imaging improvements, 77.5% manifested imaging or localized containment of mycosis improvements, and 95% exhibited imaging improvements and containment or fell within the immunotherapy timeframe. This approach demonstrated a commendable success rate coupled with minimal adverse events, spotlighting its potential, particularly for systemic antifungal non-responders or those unable to tolerate it.Non-small-cell lung cancer (NSCLC) is one of the most common cancers worldwide and causes a vast number of cancer-related deaths (11). SMARCA4, a tumor suppressor gene, is reportedly mutated in approximately 10% of NSCLC patients and associated with poor prognosis (12).While immune checkpoint inhibitors have been used to treat NSCLC, immune-related adverse events can be challenging to manage and may limit the use of these therapeutic agents (13). In their report, Deng and co-workers shared their experiences regarding a patient with SMARCA4mutant NSCLC, who developed immune-related pneumonitis during anti-PD-1 treatment and chemotherapy. Switching therapies to corticosteroids and nintedanib, an anti-fibrotic multityrosine kinase inhibitor, led to the patient's recovery and allowed chemotherapy to resume. This study illustrates an interesting strategy of using an anti-fibrotic agent to manage immunerelated adverse events and encourages further research on the applications of nintedanib with immune checkpoint inhibitors in NSCLC.In summary, this special issue provides an exhaustive insight into the current state of research related to the diagnosis and management of respiratory diseases. It highlights pioneering therapeutic targets and the emergence of novel pharmaceutical agents in the field. This collection of studies underscores not only the depth of existing knowledge but also illuminates pathways toward new therapeutic strategies. Our aspiration is to catalyze further researches, particularly in translational applications, fostering the evolution of more refined and efficacious Strategies to improve patient outcomes in clinical practice.

NW drafted the manuscript with input from HT, JL and PY. All authors contributed to the article and approved the submitted version. FUNDING

1,631 views

1 citations

Progress in understanding and treating idiopathic pulmonary fibrosis: recent insights and emerging therapies
REVIEW
7 August 2023
Progress in understanding and treating idiopathic pulmonary fibrosis: recent insights and emerging therapies
Hehua Guo, 4 more and Yulan Zeng

15,251 views

45 citations

ORIGINAL RESEARCH
4 July 2023
Drug like HSP27 cross linkers with chromenone structure ameliorates pulmonary fibrosis
Young Jo Yoo, 8 more and Yun-Sil Lee

3,482 views

5 citations

ORIGINAL RESEARCH
9 June 2023
Bronchoscopic instillation of amphotericin B is a safe and effective measure to treat pulmonary mycosis
Lei Yang, 17 more and Jing Feng

8,581 views

20 citations

ORIGINAL RESEARCH
9 March 2023
Urolithin A (UA) attenuates ferroptosis in LPS-induced acute lung injury in mice by upregulating Keap1-Nrf2/HO-1 signaling pathway
Lejing Lou, 7 more and Chang Cai

15,324 views

71 citations

ORIGINAL RESEARCH
4 April 2023
Low-dose of caffeine alleviates high altitude pulmonary edema via regulating mitochondrial quality control process in AT1 cells
Liuyang Tian, 8 more and Kunlun He

7,105 views

11 citations